丹纳赫 (Danaher) 第二季度财报评述：目前尚无吸引我逢低买入的亮点 (NYSE:DHR)
· seekingalpha.com
丹纳赫第二季度营收达到 63 亿美元，超出预期，且生物技术、诊断和生命科学各板块均实现增长。在此阅读更多关于 DHR 股票的信息。
Danaher Corporation ( DHR ) just reported its Q2 earnings , so I wanted to go through them in more detail and give some comments on the outlook and why I don’...